Related Experiment Video
Updated: Mar 25, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
Increasing Hospital Pharmacist Clinical Competence in Intensive Pharmacotherapeutics Using a Novel Pharmacist
Kelly Rudd1, J B Goss2, Amanda L Engle3
1Clinical Pharmacy Service Coordinator and Clinical Pharmacy Specialist, Anticoagulation, Bassett Medical Center , Cooperstown, New York.
Hospital Pharmacy
|February 26, 2016
Summary
A pharmacist clinical educational program significantly increased accepted clinical interventions, enhancing patient care. This training improved pharmacists' critical thinking and clinical knowledge, demonstrating an efficient method for elevating practice standards.
Area of Science:
- Pharmacology and Clinical Pharmacy
- Medical Education
- Healthcare Quality Improvement
Background:
- Intensive pharmacotherapeutics (IP) requires advanced clinical knowledge for complex patients.
- Elevating practice necessitates high levels of pharmacist competency.
Purpose of the Study:
- To develop an engaging and effective pharmacist clinical educational program.
- The program aimed to enhance pharmacists' clinical knowledge and critical thinking skills.
Main Methods:
- A 12-week educational series was implemented for hospital pharmacists.
- Primary outcome: proportion of accepted clinical interventions compared to baseline.
- Secondary outcome: participant satisfaction with the program.
Main Results:
- Accepted clinical interventions increased from 6.4% at baseline to 9.1% during and 8.7% after the program (P < .01).
- Intervention acceptance rates consistently remained above 90%.
- 94% of participants found the program met their educational needs.
Conclusions:
- Clinical educational programs are vital for advancing Intensive Pharmacotherapeutics (IP) practice.
- Efficient and cost-effective programming can be achieved by maximizing resources.
- This educational model supports clinical and organizational competency in evolving health systems.
More Related Videos
Related Concept Videos
01:27Nursing Clinical Information System
1.4K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.4K
01:28Chronic Kidney Disease III: Interprofessional Care
595
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
01:26Pharmaceutical Poisoning: Potential Scenarios
75
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
75
01:27Coronary Artery Disease V: Interprofessional Care
398
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
01:28Acute Coronary Syndrome IV: Interprofessional Care
439
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
439
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
64
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
64